Hamilton, Danilov join City of Hope

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Stanley Hamilton, formerly of MD Anderson Cancer Center, was named chair of the Department of Pathology at City of Hope, and Alexey Danilov was named associate director of City of Hope’s Toni Stephenson Lymphoma Center.

Hamilton said his goal is to bring access to state-of-the-art specialized pathology to every patient at every City of Hope satellite center, as well as improving and enhancing the biomarker data used in clinical trials, and further integrating digital pathology into the overall informatics of the institution.

Danilov brought his independently-funded lab to City of Hope’s Toni Stephenson Lymphoma Center. Danilov researches treatment of chronic lymphocytic leukemia and many forms of lymphoma.

Danilov is focused on identifying cell proteins—some that promote cancer growth, some that inhibit it—learning how they deteriorate, and finding drugs that can affect the process.

Table of Contents

YOU MAY BE INTERESTED IN

When our hematological malignancy testing pilot project began in Eldoret, Kenya, there seemed to be a mismatch in relation to progress in healthcare. The region, like much of sub-Saharan Africa, had been focusing on combatting infectious diseases such as HIV and malaria—which was much-needed—yet cancer care was under-resourced. 
Artificial intelligence is rapidly transforming biomedical research and healthcare. Large language models, foundation models, and AI agents are increasingly being deployed to assist with data interpretation, literature review, clinical decision support, and translational research. 
In modern oncology, important insights from clinical trials often emerge years after initial publication. As new therapies extend survival and transition more patients into long-term remissions, clinicians and researchers are increasingly looking beyond initial response rates to understand durability, long-term safety, and even the possibility of a cure. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login